Dynathera (DNTH) insider schedules 3,833-share stock sale under Rule 144
Rhea-AI Filing Summary
DNTH reporting person Adam M. Veness filed to sell 3,833 shares of common stock, expected on August 7, 2026, following an exercise of stock options for cash. The filing also lists prior Rule 10b5-1 plan sales of 30,000 common shares on June 17, 2026 for $2,424,033.00.
Positive
- None.
Negative
- None.
Key Figures
Planned shares to be sold: 3,833 shares of common stock
Recent 10b5-1 shares sold: 30,000 shares of common stock
Recent 10b5-1 sale proceeds: $2,424,033.00
3 metrics
Planned shares to be sold
3,833 shares of common stock
Planned sale date August 7, 2026 following stock option exercise for cash
Recent 10b5-1 shares sold
30,000 shares of common stock
Sold on June 17, 2026 under a Rule 10b5-1 plan
Recent 10b5-1 sale proceeds
$2,424,033.00
Total proceeds from sale of 30,000 common shares on June 17, 2026
Key Terms
Rule 144, 10b5-1, Exercise of Stock Options
3 terms
Rule 144 regulatory
"144: Securities To Be Sold Common | 08/07/2026 | Exercise of Stock Options"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
10b5-1 regulatory
"10b5-1 Sales for ADAM M VENESS 7 Times Square"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Exercise of Stock Options financial
"Common | 08/07/2026 | Exercise of Stock Options | Issuer"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the DNTH Rule 144 filing disclose about upcoming stock sales?
The filing shows a plan to sell 3,833 DNTH common shares on August 7, 2026 after a cash exercise of stock options by the reporting person.
What type of DNTH securities are covered by this Rule 144 notice?
The notice covers common stock of DNTH, including 3,833 shares associated with a planned stock option exercise for cash and subsequent sale on August 7, 2026.
Is the DNTH Rule 144 sale linked to stock option exercises?
Yes. The planned sale of 3,833 DNTH common shares on August 7, 2026 is tied to an exercise of stock options for cash reported in the same filing.
Who is the DNTH insider named in this Rule 144 filing?
The filing identifies Adam M. Veness, with an address at 7 Times Square in New York, as the person associated with the 10b5-1 sales and planned 3,833-share transaction.